Skip to main navigation Skip to search Skip to main content

Understanding treatment discontinuation among latent tuberculosis infection: A scoping review integrating evidence within the COM-B framework

  • Oki Nugraha Putra*
  • , Telly Purnamasari
  • , Julaeha
  • , Ema Pristi Yunita
  • , Affan Yuniar Nur Hidayatullah
  • *Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Objective: To identify tuberculosis preventive treatment nonadherence mechanisms via the Capability, Opportunity, Motivation, and Behavior (COM-B) framework for latent tuberculosis infection patients. Methods: This study was conducted in accordance with Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews guidelines. Relevant literature reporting factors associated with tuberculosis preventive treatment discontinuation or completion was included. Identified determinants were synthesized and mapped across the COM-B domains. Results: Twenty-seven studies were included. Treatment discontinuation rates varied widely (2.0%-66.8%), with consistently higher rates observed in longer regimens (6 months of isoniazid, and 9 months of isoniazid) compared with shorter regimens (3 months of isoniazid plus rifapentine, 3 months of isoniazid plus rifampin, and 4 months of rifampin). Adverse drug reactions, particularly hepatotoxicity, emerged as the most consistent predictor of discontinuation, reflecting impaired physical capability. Opportunity-related factors included healthcare system fragmentation, transportation challenges, and limited access to services. Reduced motivation was associated with stigma, low risk perception, and negative treatment beliefs. Interventions such as shorter regimens, patient-centered care, healthcare worker supervision, and digital adherence technologies were associated with improved treatment completion. These findings suggest that treatment discontinuation results from dynamic interactions between treatment-related burden, healthcare accessibility, and patient motivation. Conclusions: Clinical tolerance, structural and behavioral factors interact to cause latent tuberculosis infection discontinuation. COM-B guides targeted interventions: shorter regimens, adverse drug reaction management, and improved access and motivation.

Original languageEnglish
Pages (from-to)288-301
Number of pages14
JournalAsian Pacific Journal of Tropical Medicine
Volume19
Issue number7
DOIs
Publication statusPublished - 1 Jul 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adherence
  • COM-B
  • Latent tuberculosis infection
  • Preventative treatment
  • Treatment discontinuation

Fingerprint

Dive into the research topics of 'Understanding treatment discontinuation among latent tuberculosis infection: A scoping review integrating evidence within the COM-B framework'. Together they form a unique fingerprint.

Cite this